ESC Congress 2026 · Munich · 28–31 August

冠心病·ACS·急性心脏护理

CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE
13重点场次
5Hot Line
3中国专家参与
59中国报告
7卫星会系列
01重点学术场次Priority Sessions13 场
本专题的重点场次包含 Hot Line、LBCS、New ESC Guidelines、Ask the Trialists、Guidelines in Practice、Great Debates 等。
抗栓策略5 场Hot Line 3
Hot Line
HOT LINE 3(全球首发专场)
HOT LINE 3
时间08-29 11:00
主席Jane A Leopold; Robert Byrne
LIBREXIA ACS:近期 ACS 后使用 milvexian
LIBREXIA ACS: Milvexian after recent ACS
Philippe Gabriel Steg · 讲者 · Hospital Bichat-Claude Bernard·08-29 11:00
全球首发
PREMIUM:STEMI 直接 PCI 时省略阿司匹林
PREMIUM: Aspirin Omission at the Time of Primary PCI in STEMI
Gaku Nakazawa · 讲者 · Kindai University·08-29 11:00
全球首发
SWITCH SWEDEHEART——ACS 患者从替格瑞洛换用普拉格雷
SWITCH SWEDEHEART - Switching from ticagrelor to prasugrel in patients with ACS
Elmir Omerovic · 讲者 · Sahlgrenska University Hospital·08-29 11:00
全球首发
A-CLOSE:高危 PCI 术后氯吡格雷对比延长双联抗血小板治疗
A-CLOSE: Clopidogrel vs Extended DAPT after High-Risk PCI
Byeong-Keuk Kim · 讲者 · Severance Cardiovascular Hospital, Yonsei University College·08-29 11:00
全球首发
EPIDAURUS 试验
EPIDAURUS
Konstantinos D Rizas · 讲者 · Cantonal hospital St.Gallen·08-29 11:00
全球首发
Hot Line
HOT LINE 11(全球首发专场)
HOT LINE 11
时间08-31 13:00
主席Evelyn Regar; Bernhard Lothar Marie Gerber
EVAOLD:老年患者再灌注策略评估
EVAOLD: Evaluation of reperfusion stategies in elderly patients
Gilles Barone-Rochette · 讲者 · University Hospital of Grenoble·08-31 13:00
全球首发
ISOLEDS:远端左主干分叉病变 PCI 中 IVUS 对比 OCT 引导
ISOLEDS: IVUS vs OCT Guidance for PCI of Distal Left Main Bifurcation Lesions
Yong Zeng · 讲者 · 首都医科大学附属北京安贞医院·08-31 13:00
中国全球首发
CorCal 研究:ASCVD 一级预防中合并队列方程对比冠脉钙化积分
CorCal Study: Pooled Cohort Equations versus Coronary Artery Calcium Score in ASCVD Primary Prevention
Joseph B Muhlestein · 讲者 · Intermountain Medical Center·08-31 13:00
全球首发
CoCAP 研究:CABG 后 ACS 患者双联抗血小板或单用阿司匹林的桥血管通畅率
CoCAP Study: Graft Patency in ACS patients treated with DAPT or single Aspirin after CABG
Jonas Holm · 讲者 · Linkoping University Hospital·08-31 13:00
全球首发
Hot Line
HOT LINE 7(全球首发专场)
HOT LINE 7
时间08-30 11:00
主席Nicolas van Mieghem
POPular ACE TAVI 试验:TAVI 后常规还是选择性给予鱼精蛋白?
The POPular ACE TAVI trial: routine or selective protamine administration after TAVI?
Christiaan Overduin · 讲者 · St Antonius Hospital·08-30 11:00
全球首发
TAVI-PCI:经导管主动脉瓣植入与经皮冠状动脉介入
TAVI PCI: Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention
Barbara Elisabeth Stahli · 讲者 · University Hospital Zurich·08-30 11:00
全球首发
TRIC-I-HF:心力衰竭中的三尖瓣干预
TRIC-I-HF: Tricuspid Intervention in Heart Failure
Joerg Hausleiter · 讲者 · Ludwig Maximilians University·08-30 11:00
全球首发
ACASA-TAVI:TAVI 术后抗栓治疗
ACASA-TAVI : Antithrombotic therapy after TAVI
Oyvind H Lie · 讲者 · Oslo University Hospital Rikshospitalet·08-30 11:00
全球首发
NOTION-4:TAVI 后亚临床瓣叶血栓
NOTION-4. Subclinical leaflet thrombosis after TAVI.
Troels Hojsgaard Jorgensen · 讲者 · Rigshospitalet·08-30 11:00
全球首发
Great Debates
焦点辩论:慢性冠脉综合征患者应否以氯吡格雷替代阿司匹林
Great Debate: clopidogrel should replace aspirin for patients with chronic coronary syndromes
时间08-29 13:45
主席Gemma Vilahur; Franz Weidinger
慢性冠脉综合征患者应以氯吡格雷替代阿司匹林
Clopidogrel should replace aspirin for patients with chronic coronary syndromes
正方Daniele GiacoppoAOU Policlinico反方Bianca RoccaLUM University评论员Stefan JamesUppsala University
LBCS
晚期临床试验:急性心肌梗死管理优化
Late-Breaking Clinical Trials: optimising management of acute myocardial infarction
时间08-29 13:45
主席Gemma Figtree; Carlos L Alviar
EnVast 血栓抽吸装置作为 STEMI 的辅助再灌注手段
EnVast thrombectomy device as adjunctive reperfusion modality in ST-segment elevation myocardial infarction
Marco Valgimigli · 讲者 · Cardiocentro Ticino Institute·08-29 13:45
全球首发
STEMI 合并多支血管病变中生理学指导的分期完全血运重建的时间依赖性效应:多中心开放标签随机 STAGED 试验
Time-dependent effects of physiology-guided staged complete revascularisation in ST-segment elevation myocardial infarction with MVD disease: a multicentre, open -labelled, randomised STAGED trial
Yan Wang · 讲者 · 厦门大学附属心血管病医院·08-29 13:45
中国全球首发
高出血风险患者中使用西罗莫司涂层球囊行 PCI:SELUTION DeNovo 试验证据
Percutaneous coronary intervention using sirolimus eluting balloons in patients at high bleeding risk: Evidence from the SELUTION DeNovo trial
Tuomas Rissanen · 讲者 · North Karelia Central Hospital·08-29 13:45
全球首发
症状发作超 12 小时就诊的临床稳定 STEMI 患者中即刻对比延迟 PCI:LATE-MI 随机试验
Immediate Versus Deferred Percutaneous Coronary Intervention in Clinically Stable Patients with STEMI Presenting Beyond 12 Hours of Symptom Onset - The LATE-MI Randomized Trial
Lars Nepper-Christensen · 讲者 · Rigshospitalet·08-29 13:45
全球首发
急性心肌梗死 PCI 术后 1 个月停用阿司匹林:TARGET-FIRST 与 ULTIMATE-DAPT 随机试验的个体患者数据汇总分析
Aspirin Discontinuation 1-month After PCI in Acute Myocardial Infarction: Individual-patient-data pooled analysis of the TARGET-FIRST and ULTIMATE-DAPT randomized trials
Giuseppe Tarantini · 讲者 · University of Padua·08-29 13:45
全球首发
心肌梗死与再灌注4 场Hot Line 1
LBCS
晚期临床科学:冠状动脉微血管疾病管理
Late-Breaking Clinical Science: management of coronary microvascular disease
时间08-28 08:15
主席Vijay Kunadian; Filippo Crea
维立西呱治疗血管痉挛性心绞痛(ViVA)试验:双盲安慰剂对照随机交叉研究
The Vericiguat in Vasospastic Angina (ViVA) trial: a double-blind placebo-controlled randomized cross-over study
Hanae Namba · 讲者 · Amsterdam University Medical Centre (AUMC)·08-28 08:15
全球首发
负荷 CMR 对疑似非阻塞性冠脉心肌梗死患者冠脉微血管功能障碍检测的增量诊断价值
Incremental diagnostic value of coronary microvascular dysfunction testing in patients with a working diagnosis of myocardial infarction with nonobstructive coronary arteries by stress CMR
Jannike Nickander · 讲者 · Karolinska University Hospital·08-28 08:15
全球首发
微血管阻力储备与心血管结局:FLOW-CMD 预设分析
Microvascular Resistance Reserve and Cardiovascular Outcomes: Prespecified Analysis of FLOW-CMD
Joo Myung Lee · 讲者 · Samsung Medical Center·08-28 08:15
全球首发
MINOCA 诊断(DOMINO)登记研究:多模态影像的真实世界应用及其对病因分类的影响
The DiagnOsis of MINOCA (DOMINO) registry: a real-world use of multimodality imaging and its impact on etiologic classification
Doralisa Morrone · 讲者 · Cisanello Hospital·08-28 08:15
全球首发
CMR 心外膜脂肪组织鉴别疑似 MINOCA 病因并预测结局
CMR-Derived Epicardial Adipose Tissue Differentiates Etiologies and Predicts Outcomes in Patients With Suspected MINOCA
Wensu Chen · 讲者 · 徐州医科大学附属医院·08-28 08:15
中国全球首发
LBCS
急性冠脉综合征:诊断、危险分层与早期治疗新策略
Acute coronary syndromes: new strategies for diagnosis, risk stratification and early treatment
时间08-29 17:30
主席Jelena Rima Ghadri; Borja Ibanez
疑似 ACS 中改良 HEART 评分联合床旁高敏肌钙蛋白 I 分诊:HARTc 2.0 随机试验的临床结局
Modified HEART Score Triage With Point-of-Care hs-cTnI in Suspected ACS: Clinical Outcomes in the HARTc 2.0 Randomized Trial
Anne Catherine Mh van der Lande · 讲者 · Leiden University Medical Center·08-29 17:30
全球首发
长肌钙蛋白 T/高敏肌钙蛋白 T 比值作为 Takotsubo 综合征与急性冠脉综合征的新型鉴别指标
The Long-cTnT/hs-cTnT Ratio as a Novel Discriminator Between Takotsubo Syndrome and Acute Coronary Syndrome
Yujing Wang · 讲者 · University of Zurich·08-29 17:30
全球首发
基层医疗中基于高敏肌钙蛋白的临床决策规则排除急性冠脉综合征(POB HELP):一项诊断性试验
A Clinical Decision Rule with High-Sensitivity Troponin to Rule Out Acute Coronary Syndrome in Primary Care (POB HELP): A Diagnostic Trial
Tobias N Bonten · 讲者 · Leiden University Medical Center·08-29 17:30
全球首发
高危 STEMI 中的缺血预适应:随机多中心 RIP-HIGH 试验
Ischaemic Conditioning in High-Risk ST-elevation Myocardial Infarction: The Randomized, Multicentre, RIP-HIGH Trial
Hans-Josef Feistritzer · 讲者 · Heart Center Leipzig at University of Leipzig·08-29 17:30
全球首发
Great Debates
焦点辩论:心梗后射血分数保留患者还应继续使用 β 受体阻滞剂吗
Great Debate: no more beta-blockers for post-myocardial infarction patients with preserved left ventricular ejection fraction
时间08-31 11:15
主席Eva Prescott; Francisco Javier Rossello
心梗后射血分数保留患者不再使用 β 受体阻滞剂
No more beta-blockers for post-myocardial infarction patients with preserved left ventricular ejection fraction
正方Borja IbanezNational Centre for Cardiovascular Research CNIC AND Fundaci反方Johanne SilvainPitie-Salpetriere Hospital (APHP)评论员Dan AtarOslo University Hospital Ulleval
Hot Line
HOT LINE 4(全球首发专场)
HOT LINE 4
时间08-29 16:15
主席Alaide Chieffo; Hugo Katus
PRESC1SE-MI:ESC 0/1 小时流程的安全性与有效性
PRESC1SE-MI: Safety and efficacy of the ESC 0/1-hour algorithm
Christian Eugen Mueller · 讲者 · University Hospital Basel·08-29 16:15
全球首发
心肌梗死中 0/1 小时路径与标准诊疗路径的比较:系统综述与个体患者数据荟萃分析
Performance of 0/1-hour versus standard care pathways in myocardial infarction: a systematic review and IPDMA
Jasper Boeddinghaus · 讲者 · University Hospital Basel·08-29 16:15
全球首发
AIR-STEMI 试验:STEMI 中的功能性冠脉造影
AIR-STEMI trial: Functional Coronary Angiography in STEMI
Simone Biscaglia · 讲者 · University Hospital of Ferrara·08-29 16:15
全球首发
TARGET-CTCA——急性胸痛肌钙蛋白指导冠状动脉 CT 血管造影
TARGET-CTCA - Troponin in acute chest pain to guide CTCA
Nicholas Mills · 讲者 · University of Edinburgh·08-29 16:15
全球首发
AI 与数字技术1 场
Great Debates
焦点辩论:AI 增强冠脉 CCTA 会在近期取代有创冠脉造影吗
Great Debate: artificial intelligence-enhanced coronary computed tomography angiography will replace invasive coronary angiography in the near future
时间08-28 11:00
主席Konstantinos Toutouzas; Damini Dey
AI 增强冠脉 CCTA 将在近期取代有创冠脉造影
Artificial intelligence-enhanced coronary computed tomography angiography will replace invasive coronary angiography in the near future
正方Charalambos AntoniadesUniversity of Oxford反方Lorenz RaberSwiss Cardiovascular Center
PCI 策略与腔内影像1 场
Great Debates
焦点辩论:急性冠脉综合征的 PCI 应依据造影还是功能学指导
Great Debate: should percutaneous coronary intervention in acute coronary syndrome be angiography- or physiology-guided?
时间08-30 11:00
主席Martine Gilard; Salvatore Brugaletta
急性冠脉综合征的 PCI 应由功能学指导
Percutaneous coronary intervention in acute coronary syndrome should be physiology-guided
正方Gianluca CampoUniversity Hospital of Ferrara反方Robert ByrneMater Private Hospital评论员Dawn Louise AdamsonUniversity Hospitals of Coventry and Warwickshire NHS Trust
心脏骤停与危重症1 场Hot Line 1
Hot Line
HOT LINE 12(全球首发专场)
HOT LINE 12
时间08-31 14:15
主席Anne Freund; Christian Hassager
DISCO 试验:复苏成功的院外心脏骤停且无心电图 ST 段抬高患者行急诊冠脉造影
DISCO trial: Acute coronary angiography after resuscitated out-of-hospital cardiac arrest without ST-elevation on the ECG
Sten Rubertsson · 讲者 · Uppsala University·08-31 14:15
全球首发
无 ST 段抬高的院外心脏骤停后的冠脉造影
CAG after OHCA without ST-elevation
Lente Pol · 讲者 · Radboud University Medical Centre·08-31 14:15
全球首发
HeartRunner 试验:社区第一响应者激活后的院外心脏骤停生存率
The HeartRunner Trial: Out-of-Hospital Cardiac Arrest Survival following Community First Responder activation
Fredrik Folke · 讲者 · Herlev Gentofte University Hospital, Copenhagen, Denmark·08-31 14:15
全球首发
布拉格 26 研究:导管引导溶栓治疗肺栓塞
Prague 26: catheter-directed thrombolysis for pulmonary embolism
Viktor Kocka · 讲者 · Third Faculty of Medicine, Charles University and University·08-31 14:15
全球首发
LAACS-2:外科左心耳封堵 2
LAACS-2. Left Atrial Appendage Closure with Surgery-2
Helena Dominguez · 讲者 · Bispebjerg University Hospital·08-31 14:15
全球首发
其他1 场
Great Debates
焦点辩论:急性冠脉综合征应常规完全血运重建还是仅处理罪犯血管
Great Debate: routine complete or culprit-only revascularisation for acute coronary syndromes?
时间08-29 11:00
主席Diana A Gorog; Stephane Manzo-Silberman
所有急性冠脉综合征患者都应常规完全血运重建
All patients with acute coronary syndromes should have routine complete revascularisation
正方Barbara Elisabeth StahliUniversity Hospital Zurich反方Holger ThieleHeart Center Leipzig at University of Leipzig评论员Franz WeidingerLandstrasse Clinic
02中国专家参与场次China Faculty3 场
中国专家参与的报告
抗栓策略 · 2 项中国专家报告
ISOLEDS:远端左主干分叉病变 PCI 中 IVUS 对比 OCT 引导
ISOLEDS: IVUS vs OCT Guidance for PCI of Distal Left Main Bifurcation Lesions
Yong Zeng · 讲者 · 首都医科大学附属北京安贞医院·08-31 13:00
中国全球首发
STEMI 合并多支血管病变中生理学指导的分期完全血运重建的时间依赖性效应:多中心开放标签随机 STAGED 试验
Time-dependent effects of physiology-guided staged complete revascularisation in ST-segment elevation myocardial infarction with MVD disease: a multicentre, open -labelled, randomised STAGED trial
Yan Wang · 讲者 · 厦门大学附属心血管病医院·08-29 13:45
中国全球首发
心肌梗死与再灌注 · 1 项中国专家报告
CMR 心外膜脂肪组织鉴别疑似 MINOCA 病因并预测结局
CMR-Derived Epicardial Adipose Tissue Differentiates Etiologies and Predicts Outcomes in Patients With Suspected MINOCA
Wensu Chen · 讲者 · 徐州医科大学附属医院·08-28 08:15
中国全球首发
03本领域中国研究China Abstracts59 篇
研究标题第一作者所在机构
流行病学、预后与结局 · 10 篇
弥合区域差距:中国低GDP地区早发急性冠脉综合征死亡率下降趋势:中国心血管协会(CCA)数据库-胸痛中心的结果
Bridging the regional gap: declining mortality trends in early onset acute coronary syndrome in low GDP region of China: findings from the Chinese Cardiovascular Association (CCA) database-chest pain
08-28 08:15
Yitian Chen首都医科大学附属北京友谊医院
收缩压与舒张压和心肌梗死后远期结局的相关性
Association of systolic and diastolic blood pressures with long-term outcomes after myocardial infarction
08-28 09:15
Wen-Yi Yang上海交通大学附属第一人民医院
569例川崎病患儿冠状动脉病变的中远期结局与重构
Mid- to long-term outcomes and remodeling of coronary artery lesions in 569 children with kawasaki disease
08-28 09:15
Bo Han山东省立医院
Fibrosis-4定义的肝纤维化、传统危险因素与急性冠脉综合征患者心血管事件
Fibrosis-4 –defined liver fibrosis, traditional risk factors, and cardiovascular events in patients with acute coronary syndrome
08-30 11:15
Xiangyun Kong首都医科大学附属北京朝阳医院
中国缺血性心脏病负担与护理质量的演变:现状、三十年趋势与2050年预测
The evolving burden and nursing quality of ischemic heart disease in china: current status, three decades of trends, and 2050 forecast
08-30 13:15
Juwei Dong北京中医药大学东直门医院
心血管-肾脏-代谢共病与超重及非超重急性心肌梗死患者的死亡风险
Cardiovascular-kidney-metabolic comorbidities and mortality risk in overweight and non‑overweight patients with acute myocardial infarction
08-30 14:15
Ruiqi Zhang国家心血管病中心、阜外医院心血管疾病国家重点实验室
可穿戴同步心音-心电图设备的电机械激活时间预测急性心肌梗死左室收缩功能障碍与预后
ElectroMechanical Activation Time (EMAT) from wearable synchronous phonocardiogram-electrocardiogram device predicts left ventricular systolic dysfunction and prognosis in acute myocardial infarction
08-30 14:15
Xiaoshu Cheng南昌大学第二附属医院
基于双能量冠状动脉CT造影预测复发性心绞痛的整合临床-影像组学模型
An integrative clinical-radiomic model for predicting recurrent angina based on dual-energy coronary CT angiography
08-30 17:15
Wenyi Tang中山大学附属第五医院
急性冠脉综合征出院后一年内主要不良心血管事件的机器学习风险预测模型
A machine learning-based risk prediction model for major adverse cardiovascular events within one year after discharge in patients with acute coronous syndrome
08-31 14:15
Tiantian Li中国疾病预防控制中心
阻塞性睡眠呼吸暂停、胰岛素抵抗与急性冠脉综合征的远期心血管结局
Obstructive sleep apnea, insulin resistance and long-term cardiovascular outcomes in acute coronary syndrome
08-31 14:15
Feiyu Zhang首都医科大学附属北京安贞医院
ST段抬高型心肌梗死 · 8 篇
STEMI患者的医院水平差异与远期生存:全国队列研究证据
Hospital-level disparities and long-term survival in patients with ST-segment elevation myocardial infarction: evidence from a nationwide cohort study
08-28 08:15
Feilong Chen国家心血管病中心、阜外医院心血管疾病国家重点实验室
18F-FAPI-04 PET/MRI多维度评估冠心病心肌纤维化
Multidimensional assessment of myocardial fibrosis in coronary heart disease using 18F-FAPI-04 PET/MRI
08-28 08:15
Bo Zhang大连医科大学附属第一医院
数据驱动识别急性心肌梗死不同亚表型:中国急性心肌梗死注册研究的启示
Data-driven identification of distinct subphenotypes in acute myocardial infarction: insights from the China acute myocardial infarction registry
08-29 16:15
Zuoxiang Wang中国医学科学院北京协和医学院阜外医院
卒中诱导的心脏免疫重构可能影响后续心肌梗死的心脏结局
Stroke-induced cardiac immune remodeling may influence cardiac outcomes in subsequent myocardial infarction
08-30 11:15
Chenyan Liu复旦大学附属中山医院
酮替芬用于STEMI直接PCI患者的疗效与安全性临床研究
Clinical study on the efficacy and safety of ketotifen in STEMI patients undergoing primary PCI
08-30 13:15
Pengxin Xie北京大学第三医院
比伐芦定对比肝素在高出血风险与低出血风险STEMI直接PCI患者中的应用:BRIGHT-4试验预设分析
Bivalirudin versus heparin in high and low bleeding risk patients undergoing primary PCI for STEMI: pre-specified analysis from the BRIGHT-4 trial
08-30 13:45
Miaohan Qiu北部战区总医院
罗沙司他早期应用于直接PCI后的STEMI患者:随机临床试验
Early use of roxadustat in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: a randomised clinical trial
08-30 13:25
Yueying Wang上海交通大学医学院附属瑞金医院
造影衍生桡向管壁应变预测急性心肌梗死患者非罪犯血管轻中度病变的血运重建
Angiographically derived radial wall strain predicts revascularization of mild-to-intermediate lesions in non-culprit vessels among patients with acute myocardial infarction
08-30 15:15
Danbo Lu复旦大学附属中山医院
生物标志物 · 7 篇
SUA/eGFR比值预测STEMI早期硬事件的优越性:大规模头对头比较与J型风险发现
Superiority of the SUA/eGFR Ratio in predicting early hard events in STEMI: A large-scale head-to-head comparison and J-shaped risk discovery
08-28 16:15
Kang-Yin Chen天津医科大学第二医院
C反应蛋白-甘油三酯-葡萄糖指数与意义未明克隆性造血对STEMI患者的预测价值:前瞻性队列研究
The predictive value of C-reactive protein-triglyceride-glucose index and clonal hematopoiesis of indeterminate potential among patients with STEMI---from a prospective cohort study
08-28 16:15
Xiaoxiao Zhao国家心血管病中心、阜外医院心血管疾病国家重点实验室
同型半胱氨酸倍增早发心肌梗死不良结局风险:与肥胖和炎症的协同效应
Homocysteine multiplies risks of adverse outcomes in premature myocardial infarction: synergistic effects with obesity and inflammation
08-29 09:30
Jing Gao天津市胸科医院
冠心病鞘脂代谢相关生物标志物鉴定与分子机制研究
Identification of sphingolipid metabolism-related biomarkers and molecular mechanism study in coronary heart disease
08-29 11:15
Si Wei Chen南昌市第三医院
支链氨基酸心血管效应的生物学机制:蛋白质组范围孟德尔随机化研究
Biological mechanisms underlying the cardiovascular effects of branch-chain amino acids: a proteome-wide mendelian randomisation study
08-30 08:15
Jie Zhao香港大学
即时检测(POCT)与肌钙蛋白在急性胸痛患者中的应用
Utilization of Point-Of-Care Testing (POCT) or troponin in patients with acute chest pain
08-31 08:15
Hang Long Li香港大学
生长刺激表达基因2在冠心病患者中的诊断与预后价值
The diagnostic and prognostic value of growth stimulation expressed gene 2 in patients with coronary artery disease
08-31 11:15
Yang-Yang Qu东南大学附属中大医院
药物治疗 · 5 篇
养心氏与无既往心血管事件的冠心病患者1年全因死亡的关联
Association between yangxinshi and 1-year all-cause mortality in patients with coronary artery disease without prior cardiovascular events
08-31 11:15
Kang-Yin Chen天津医科大学第二医院
院内启动PCSK9抑制剂对急性冠脉综合征远期血脂稳定性影响的因果中介与机器学习分析
Causal mediation and machine learning analysis of in-hospital PCSK9 inhibitor initiation on long-term lipid stability in acute coronary syndrome
08-31 12:15
Yani Yu中国人民解放军总医院
阿司匹林对比吲哚布芬治疗NSTEMI患者的一年临床结局:多中心回顾性队列研究
One-year clinical outcomes of aspirin versus indobufen in patients with NSTEMI: a multicenter retrospective cohort study
08-31 12:15
Hao Zhang天津医科大学第二医院
他汀初治急性冠脉综合征早期强化联合降脂治疗:真实世界血脂达标与治疗缺口分析
Early intensive combination lipid-lowering therapy in statin-naïve acute coronary syndrome: real-world attainment of lipid targets and analysis of therapeutic gaps
08-31 12:15
Guang Ming Tan香港中文大学
血运重建后射血分数保留的ACS患者长期β受体阻滞剂治疗:多中心回顾性队列研究
Long-term beta-blocker therapy after revascularised acute coronary syndrome (ACS) with preserved ejection fraction: a multi-centre retrospective cohort study
08-31 12:15
Jih Tze Tan大林慈济医院
炎症 · 3 篇
巨噬细胞FOXK2促进应激性高血糖心肌梗死后的心脏修复
Macrophage FOXK2 promotes cardiac repair in myocardial infarction with stress hyperglycemia
08-29 13:25
Junguo Jin北京大学第一医院
局部与全身炎症对冠心病PCI术后血管导向结局的比较影响
Comparative impact of local and systemic inflammation on vessel-oriented outcomes following PCI in coronary artery disease
08-29 13:45
Zixiang Ye国家心血管病中心、阜外医院心血管疾病国家重点实验室
炎症指数显著改善STEMI患者一年死亡预测:大规模多中心研究
Inflammatory indices significantly improve one-year mortality prediction in STEMI patients: a large-scale multi-center study
08-31 13:15
Kang-Yin Chen天津医科大学第二医院
易损斑块 · 3 篇
非高胆固醇血症患者中脂蛋白(a)与冠状动脉高危斑块相关吗?OCT影像的启示
Does lipoprotein(a) associate with coronary high-risk plaque in patients without hypercholesterolemia? Insights from optical coherence tomography imaging
08-29 14:05
Chao Fang哈尔滨医科大学附属第二医院
冠脉CT造影脂肪衰减指数与斑块特征和OCT识别高危斑块的相关性
Fat attenuation index and plaque characteristics on coronary computed tomography angiography correlation with high-risk plaques identified by optical coherence tomography
08-30 17:15
Lei Guo大连医科大学附属第一医院
ApoC3介导PM2.5诱发动脉粥样硬化性心血管疾病的机制
Mechanisms underlying ApoC3-mediated PM2.5-Induced atherosclerotic cardiovascular disease
08-31 13:15
Yixue Zhao北京大学第一医院
炎症与免疫 · 2 篇
梗死后抗炎治疗的靶向安全策略:经仿生纳米载体实现心脏限制性NLRP3抑制
A targeted and safe strategy for post-infarction anti-inflammatory therapy: cardiac-restricted NLRP3 inhibition via a biomimetic nanocarrier
08-28 14:30
Ziqin Zhou广东省心血管病研究所
冠状动脉粥样硬化新型组织蛋白组学分型识别CAPG为斑块失稳的关键炎症驱动因子
Novel histo-proteomic subtyping of coronary atherosclerosis identifies CAPG as a key inflammatory driver in plaque destabilisation
08-29 14:03
Xinjie Xu国家心血管病中心、阜外医院心血管疾病国家重点实验室
血栓、血小板与凝血 · 2 篇
ASIC3激活抑制血栓形成:机体的自我保护机制
Activation of ASIC3 attenuates thrombogenesis: a self-protective mechanism of the body
08-29 13:15
Peng Zhang上海市第九人民医院
高血压相关乙酸缺乏经Olfr78增强血小板活化与血栓形成
Hypertension-associated acetate deficiency enhances platelet activation and thrombosis via Olfr78
08-30 10:15
Yufei Chen华山医院
04企业卫星会Industry Symposia7 个系列
赞助商分布3 场 · Medtronic 1 场 · Chiesi 1 场 · Zentiva 1 场 · Novo Nordisk 1 场 · Amgen
炎症与残余风险2 个系列
Zentiva
为心血管炎症降温:2026 年有哪些治疗选择
Cooling the fire of cardiovascular inflammation: what are the treatment options in 2026?
日程08-28
欢迎与介绍
Welcome and introduction
炎症作为动脉粥样硬化的治疗靶点:我们对残余炎症与可用治疗了解多少?
Inflammation as a therapeutic target in atherosclerosis: what do we know about residual inflammation and available treatments?
Paul M Ridker · 讲者 · Brigham and Women's Hospital
动脉粥样硬化性心血管疾病患者的炎症减轻
Inflammation reduction in patients with atherosclerotic cardiovascular disease
Jean-Claude Tardif · 讲者 · Montreal Heart Institute
治疗谁、何时治疗:从临床研究与指南到临床实践——讨论
Whom to treat and when to treat: from clinical studies and guidelines to clinical practice - discussion
Wolfgang Koenig · 评论员 · Technical University of Munich、Lale Tokgozoglu · 评论员 · Hacettepe University 等 4 人
Novo Nordisk
心血管炎症:受审的沉默杀手
Cardiovascular inflammation: the silent killer on trial
日程08-29
欢迎与介绍
Welcome and introductions
Paul M Ridker · 讲者 · Brigham and Women's Hospital
心血管炎症的视角
Perspectives on cardiovascular inflammation
Paul M Ridker · 讲者 · Brigham and Women's Hospital
心血管炎症的患病率
The prevalence of cardiovascular inflammation
Nikolaus Marx · 讲者 · RWTH University Hospital Aachen
心血管炎症领域不断演进的临床指南
Evolving clinical guidelines in cardiovascular inflammation
Vijay Kunadian · 讲者 · Newcastle University
总结与闭幕
Summary and close
Paul M Ridker · 评论员 · Brigham and Women's Hospital
心脏骤停与危重症1 个系列
Chiesi
快速起效、精准可控:静脉 P2Y12 抑制剂在 CCS、ACS 与心源性休克中的角色演进
Rapid power, precise control: the evolving role of intravenous P2Y12 inhibition in chronic coronary syndromes, acute coronary syndromes, and cardiogenic shock
日程08-28
开幕致辞
Opening address
Piera Capranzano · 讲者 · University of Catania
急性冠脉综合征挑战:PCI 中速度优先
The acute coronary syndrome challenge: speed as a priority in PCI
Dominick Joseph Angiolillo · 讲者 · University of Florida College of Medicine – Jacksonville
慢性冠脉综合征中静脉抗血小板治疗的个体化
Tailoring IV antiplatelet therapy in chronic coronary syndromes
Francesco Pelliccia · 讲者 · Sapienza University of Rome
休克因素:优化抗血小板治疗
The shock factor: optimising antiplatelet therapy
Jolanta Siller-Matula · 讲者 · Medical University of Vienna
快速起效、精准控制:静脉 P2Y12 抑制在慢性冠脉综合征、急性冠脉综合征和心源性休克中不断演变的作用——讨论与问答
Rapid power, precise control: the evolving role of intravenous P2Y12 inhibition in chronic coronary syndromes, acute coronary syndromes, and cardiogenic shock - discussion and Q&A
PCI 策略与腔内影像1 个系列
Medtronic
冠脉生理学新标准:基于造影的 FFR 及其临床决策价值
The new standard in coronary physiology: angio‑based FFR and its role in clinical decision-making
日程08-28
冠脉生理学的新标准:基于血管造影的 FFR 及其在临床决策中的作用
The new standard in coronary physiology: angio‑based FFR and its role in clinical decision-making
Ioannis Skalidis · 讲者 · Fribourg Hospital、Martin Janet · 讲者 · France
降脂新药(PCSK9/Lp(a))1 个系列
Amgen
冠心病 LDL-C 管理:是否应该从导管室开始
Low-density lipoprotein cholesterol management in coronary artery disease: should it begin in the cath lab?
日程08-30
欢迎与学习目标
Welcome and learning objectives
Vijay Kunadian · 讲者 · Newcastle University
从急性冠脉综合征到早期血脂干预:ARMYDA 及更多研究的经验
From acute coronary syndrome to early lipid intervention: lessons from ARMYDA and beyond
Giuseppe Patti · 讲者 · University of Eastern Piedmont
斑块影像教给我们关于早期强化降低 LDL-C 的什么知识
What plaque imaging teaches us about early intensive low-density lipoprotein cholesterol lowering
Ulrich Laufs · 讲者 · University Hospital Leipzig
AMUNDSEN 试验结果:早期低密度脂蛋白胆固醇管理的当代证据
AMUNDSEN Trial results: contemporary evidence for early low-density lipoprotein cholesterol management
Gilles Montalescot · 讲者 · Sorbonne University
EVOLVE-MI 与真实世界证据:从试验信号到体系变革
EVOLVE-MI and real-world evidence: from trial signal to system change
Marc Bonaca · 评论员 · University of Colorado Anschutz Medical Campus
专家讨论:LDL-C 管理是否应从导管室开始?
Panel discussion: should low-density lipoprotein cholesterol management begin in the cath lab?
综合与其他2 个系列
Medtronic
TAVI 入门:早期识别与转诊要点
Introduction to TAVI: essentials for early recognition and referral
日程08-28
TAVI 入门:早期识别与转诊要点
Introduction to TAVI: essentials for early recognition and referral
Arif Khokhar · 讲者 · Rigshospitalet
Medtronic
TAVI 患者旅程:从首次识别到专科转诊
The TAVI patient journey: from first identification to specialist referral
日程08-30
TAVI 患者之旅:从首次识别到专科转诊
The TAVI patient journey: from first identification to specialist referral
Caterina Cavazza · 讲者 · Infermi Hospital of Rimini
企业卫星会内容由赞助方支持,此处仅作学术日程信息陈列,不代表编辑立场。
✕ 关闭
A-CLOSE
A-CLOSE: Clopidogrel vs Extended DAPT after High-Risk PCI
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
A Clinical Decision Rule with High-Sensitivity Troponin to Rule Out Acute Coronary Syndrome in Primary Care (POB HELP)
A Clinical Decision Rule with High-Sensitivity Troponin to Rule Out Acute Coronary Syndrome in Primary Care (POB HELP): A Diagnostic Trial
注册记录待核
文章
Current opinion in cardiology · 2026 · PMID 42647416
Photon-counting detector computed tomography (PCD-CT) is an emerging technology that addresses key limitations of conventional coronary CT angiography, including calcium blooming, stent-related artifacts, and limited spatial resolution. This review summarizes recent evidence regarding the diagnostic performance and cli…
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
ACASA-TAVI
ACASA-TAVI : Antithrombotic therapy after TAVI
已有发表积累
研究
注册号
NCT01559298
状态
已随访完成
期别/类型
PHASE4 期 · INTERVENTIONAL
入组
178 人(1 国)
启动
2012-03
主要研究者
Oyvind H Lie · Oslo University Hospital Rikshospitalet - Oslo, Norway
主要终点
死亡、心肌梗死、缺血性卒中/短暂性脑缺血发作或危及生命/大出血的发生率
文章
American heart journal · 2023 · PMID 37634655
The trial is planned, initiated, funded, and conducted without industry involvement.
AIR-STEMI
AIR-STEMI trial: Functional Coronary Angiography in STEMI
已有发表积累
研究
注册号
NCT07176104
状态
NOT_YET_RECRUITING
期别/类型
无期别 期 · INTERVENTIONAL
入组
140 人(1 国)
启动
2026-07
主要研究者
Simone Biscaglia · University Hospital of Ferrara - Ferrara, Italy
主要终点
12个月支架内再狭窄发生率 ① 主要不良心血管事件(MACE)
文章
American heart journal · 2025 · PMID 39984150
Complete revascularization has been shown to be superior to culprit-only treatment in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. However, it remains unclear whether complete revascularization should be guided by coronary physiology or conventional angiography. Angiography-…
Aspirin Discontinuation 1-month After PCI in Acute Myocardial Infarction
Aspirin Discontinuation 1-month After PCI in Acute Myocardial Infarction: Individual-patient-data pooled analysis of the TARGET-FIRST and ULTIMATE-DAPT randomized trials
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
CoCAP
CoCAP Study: Graft Patency in ACS patients treated with DAPT or single Aspirin after CABG
全球首发信号
研究
注册号
NCT04783701
状态
入组中
期别/类型
— · OBSERVATIONAL
入组
360 人(2 国)
启动
2021-05-17
主要研究者
Jonas Holm · Linkoping University Hospital - Linkoping, Sweden
主要终点
CABG后桥血管通畅率
首发
会前无公开结果文献 —— ESC 2026 现场即全球首发的报道窗口
CorCal
CorCal Study: Pooled Cohort Equations versus Coronary Artery Calcium Score in ASCVD Primary Prevention
注册记录待核
文章
American heart journal · 2026 · PMID 42106092
Two methods to select statin therapy for primary prevention are the pooled cohort equation (PCE), based on traditional risk factors, and coronary artery calcium (CAC), a patient-level assessment of coronary plaque burden. How well these methods compare in reducing atherosclerotic cardiovascular disease (ASCVD) outcomes…
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
DISCO
DISCO trial: Acute coronary angiography after resuscitated out-of-hospital cardiac arrest without ST-elevation on the ECG
已有发表积累
研究
注册号
NCT04766190
状态
入组完成·随访中
期别/类型
无期别 期 · INTERVENTIONAL
入组
254 人(1 国)
启动
2021-02-10
主要研究者
Sten Rubertsson · Uppsala University - Uppsala, Sweden
主要终点
医患互动自我效能(PEPPI量表示例:您对自己能否知道该问医生什么问题有多大信心?数据将以均值和标准差汇总) ① 治疗成本管理自我效能(改编量表示例:我有信心支付直接治疗成本。数据将以均值和标准差汇总) ① 治疗成本类型认知(原量表示例:癌症治疗可能产生哪些费用?数据将以频次汇总)
文章
American heart journal · 2026 · PMID 41115584
DISCO COMPLEX is the first randomized clinical trial designed to test the superiority of large-bore DRA over conventional TRA in reducing RAO rates among patients undergoing complex PCI with 7-Fr guide catheters.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026 · PMID 42608965
DiagnOsis of MINOCA (DOMINO) registry
The DiagnOsis of MINOCA (DOMINO) registry: a real-world use of multimodality imaging and its impact on etiologic classification
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
EPIDAURUS
EPIDAURUS
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
EVAOLD
EVAOLD: Evaluation of reperfusion stategies in elderly patients
注册记录待核
文章
American heart journal · 2025 · PMID 39447717
EVAOLD is a nationwide, prospective, open-label trial testing the noninferiority of a strategy of selective invasive management guided by ischemia stress imaging versus routine invasive strategy in elderly NSTEMI patients.
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
HeartRunner
The HeartRunner Trial: Out-of-Hospital Cardiac Arrest Survival following Community First Responder activation
已有发表积累
研究
注册号
NCT07589504
状态
NOT_YET_RECRUITING
期别/类型
— · OBSERVATIONAL
入组
5,200 人(1 国)
启动
2026-05
主要研究者
Fredrik Folke · Herlev Gentofte University Hospital, Copenhagen, Denmark - Hellerup, Denmark
主要终点
院外心脏骤停后30天生存率
文章
Resuscitation plus · 2023 · PMID 37007187
Our findings support the importance of validating questionnaires to ensure accuracy of survey instruments. Validation led to modifications of the questionnaire, and we propose a new version of the HeartRunner questionnaire. Our findings support the content validity of the final HeartRunner questionnaire. The questionnaire may allow the collection of quality data to evaluate and improve volunteer responder programmes.
Journal of the American College of Cardiology · 2020 · PMID 32616162
ISOLEDS
ISOLEDS: IVUS vs OCT Guidance for PCI of Distal Left Main Bifurcation Lesions
注册记录待核
文章
Contemporary clinical trials · 2024 · PMID 39277167
Percutaneous coronary intervention (PCI) can provide benefits for anatomically suitable left main coronary artery (LMCA) lesions. When compared to traditional coronary angiography (CAG) -guided PCI, the use of intravascular ultrasound (IVUS) guidance has shown significant long-term prognostic improvements in LMCA PCI. …
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
Ischaemic Conditioning in High-Risk ST-elevation Myocardial Infarction
Ischaemic Conditioning in High-Risk ST-elevation Myocardial Infarction: The Randomized, Multicentre, RIP-HIGH Trial
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
LAACS-2
LAACS-2. Left Atrial Appendage Closure with Surgery-2
已有发表积累
研究
注册号
NCT03724318
状态
入组完成·随访中
期别/类型
无期别 期 · INTERVENTIONAL
入组
1,500 人(3 国)
启动
2019-03-17
主要研究者
Helena Dominguez · Bispebjerg University Hospital - Copenhagen, Denmark
主要终点
卒中(包括短暂性脑缺血发作)发生参与者数
LATE-MI
Immediate Versus Deferred Percutaneous Coronary Intervention in Clinically Stable Patients with STEMI Presenting Beyond 12 Hours of Symptom Onset - The LATE-MI Randomized Trial
注册记录待核
文章
Frontiers in cardiovascular medicine · 2021 · PMID 35127842
Although not statistically beneficial for MACE, target vessel revascularization, periprocedural, and late MI, EPD use does appear to significantly reduce mortality for the patients undergoing PCI in SVG. Clinicians might consider using EPD for such patients to reduce the burden of post-procedural morbidity and mortality.
Cardiology research and practice · 2020 · PMID 32550021
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
LIBREXIA ACS
LIBREXIA ACS: Milvexian after recent ACS
已有发表积累
研究
注册号
NCT05754957
状态
已随访完成
期别/类型
III 期 · INTERVENTIONAL
入组
14,194 人(44 国)
启动
2023-04-07
主要研究者
Philippe Gabriel Steg · Hospital Bichat-Claude Bernard - Paris, France
主要终点
首次主要不良心血管事件(MACE)发生时间
文章
American heart journal · 2025 · PMID 39986336
Despite current antiplatelet therapy, patients remain at risk of recurrent ischemic events after acute coronary syndromes (ACS), which may reflect persistently elevated thrombin generation. Factor XIa inhibition reduces thrombin generation and may improve clinical outcomes with minimal bleeding risk. Librexia ACS (Clin…
Journal of thrombosis and haemostasis : JTH · 2026 · PMID 41791675
Microvascular Resistance Reserve and Cardiovascular Outcomes
Microvascular Resistance Reserve and Cardiovascular Outcomes: Prespecified Analysis of FLOW-CMD
注册记录待核
文章
The lancet. Diabetes & endocrinology · 2026 · PMID 42567173
The GLP-1 receptor agonist semaglutide reduces clinically important kidney outcomes in people with type 2 diabetes and chronic kidney disease (CKD). We aimed to assess the pooled effects of semaglutide on kidney outcomes in prespecified analyses of participant-level data from the diverse populations of the SELECT, FLOW…
Journal of magnetic resonance imaging : JMRI · 2026 · PMID 42565288
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
Modified HEART Score Triage With Point-of-Care hs-cTnI in Suspected ACS
Modified HEART Score Triage With Point-of-Care hs-cTnI in Suspected ACS: Clinical Outcomes in the HARTc 2.0 Randomized Trial
注册记录待核
文章
American heart journal · 2025 · PMID 40675207
This trial evaluates modified HEART score with POC hs-cTnI testing, incorporating sex-specific cut-offs, to improve prehospital ACS risk stratification. Phases 0 and 1 confirm the reliability of capillary whole blood POC hs-cTnI. Furthermore, the trial is a randomized trial which evaluates prehospital risk stratification for ACS using a 0/2-hour POC hs-cTnI algorithm on clinical decision-making, time-to-diagnosis, as well as its cost-effectiveness. Improved prehospital risk stratification for ACS aims to enhance triage accuracy, time-to-diagnosis and time-to-treatment, thereby reducing unnecessary hospital admissions and improve resource allocation in prehospital and emergency care.
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
CAG after OHCA without ST-elevation
CAG after OHCA without ST-elevation
全球首发信号
研究
注册号
NCT02387398
状态
已终止
期别/类型
无期别 期 · INTERVENTIONAL
入组
99 人(3 国)
启动
2016-01-01
主要研究者
Lente Pol · Radboud University Medical Centre - Nijmegen, Netherlands (The)
主要终点
院外心脏骤停(OHCA)患者早期冠脉造影的安全性和疗效
首发
会前无公开结果文献 —— ESC 2026 现场即全球首发的报道窗口
CMR-Derived Epicardial Adipose Tissue Di
CMR-Derived Epicardial Adipose Tissue Differentiates Etiologies and Predicts Outcomes in Patients With Suspected MINOCA
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
EnVast thrombectomy device as adjunctive
EnVast thrombectomy device as adjunctive reperfusion modality in ST-segment elevation myocardial infarction
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
Incremental diagnostic value of coronary
Incremental diagnostic value of coronary microvascular dysfunction testing in patients with a working diagnosis of myocardial infarction with nonobstructive coronary arteries by stress CMR
注册记录待核
文章
Cardiovascular revascularization medicine : including molecular interventions · 2025 · PMID 40562606
The combination of IMR and MRR enhanced diagnostic specificity for CMD in patients with ANOCA, highlighting their complementary value. Future studies should focus on larger cohorts to validate these findings.
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
The Long-cTnT/hs-cTnT Ratio as a Novel D
The Long-cTnT/hs-cTnT Ratio as a Novel Discriminator Between Takotsubo Syndrome and Acute Coronary Syndrome
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
NOTION-4
NOTION-4. Subclinical leaflet thrombosis after TAVI.
已有发表积累
研究
注册号
NCT06449469
状态
入组完成·随访中
期别/类型
无期别 期 · INTERVENTIONAL
入组
352 人(1 国)
启动
2021-05-01
主要研究者
Troels Hojsgaard Jorgensen · Rigshospitalet - Copenhagen University Hospital - Copenhagen, Denmark
主要终点
1年后HALT
文章
American heart journal · 2025 · PMID 39374638
Transcatheter aortic valve replacement (TAVR) has become the standard-of-care treatment for a majority of patients with severe, symptomatic aortic stenosis. The postprocedural antithrombotic therapeutic management is still a topic of debate and could affect the incidence of HALT, a phenomenon which can be assessed by 4…
PREMIUM
PREMIUM: Aspirin Omission at the Time of Primary PCI in STEMI
全球首发信号
研究
注册号
NCT01756625
状态
未知
期别/类型
— · OBSERVATIONAL
入组
500 人(1 国)
启动
2010-01
主要研究者
Gaku Nakazawa · Kindai University - Osaka, Japan
主要终点
与临床研究中1年无进展生存率(PFS)比较(ITT和亚组分析)
首发
会前无公开结果文献 —— ESC 2026 现场即全球首发的报道窗口
PRESC1SE-MI
PRESC1SE-MI: Safety and efficacy of the ESC 0/1-hour algorithm
已有发表积累
研究
注册号
NCT05649384
状态
入组完成·随访中
期别/类型
无期别 期 · INTERVENTIONAL
入组
64,374 人(11 国)
启动
2020-12-01
主要研究者
Christian Eugen Mueller · University Hospital Basel - Basel, Switzerland
主要终点
索引就诊后30天内全因死亡或新发1型心肌梗死复合终点 ① 急诊就诊至离院或转诊时间
文章
American heart journal · 2026 · PMID 41177204
PRESC1SE-MI is the largest international multicenter trial to date evaluating the safety and the efficacy of the implementation of the more rapid ESC 0/1h-algorithm at late adopting centers across multiple countries and healthcare systems. Its findings have the potential to improve patient care and reduce healthcare costs.
Percutaneous coronary intervention using sirolimus eluting balloons in patients at high bleeding risk
Percutaneous coronary intervention using sirolimus eluting balloons in patients at high bleeding risk: Evidence from the SELUTION DeNovo trial
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
Performance of 0/1-hour versus standard care pathways in myocardial infarction
Performance of 0/1-hour versus standard care pathways in myocardial infarction: a systematic review and IPDMA
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
Prague 26
Prague 26: catheter-directed thrombolysis for pulmonary embolism
已有发表积累
研究
注册号
NCT04790370
状态
入组完成·随访中
期别/类型
PHASE4 期 · INTERVENTIONAL
入组
544 人(9 国)
启动
2021-08-02
主要研究者
Viktor Kocka · Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady - Prague, Czechia
主要终点
肺栓塞相关死亡 ① 肺栓塞复发 ① 心肺失代偿或崩溃
文章
Anatolian journal of cardiology · 2026 · PMID 42552776
In IHR PE, IV low-dose tPA relates to more pronounced early hemodynamic and RV diameter improvements, whereas USAT achieves superior thrombus resolution. Despite these divergent surrogate responses, both strategies yield comparable early and long-term clinical outcomes, supporting their roles as viable reperfusion options.
SWITCH SWEDEHEART
SWITCH SWEDEHEART - Switching from ticagrelor to prasugrel in patients with ACS
全球首发信号
研究
注册号
NCT02016170
状态
已随访完成
期别/类型
无期别 期 · INTERVENTIONAL
入组
82 人(1 国)
启动
2014-03
主要研究者
Elmir Omerovic · Sahlgrenska University Hospital - Gothenburg, Sweden
主要终点
Verify Now-P2Y12检测的P2Y12反应单位(PRU)血小板反应性
首发
会前无公开结果文献 —— ESC 2026 现场即全球首发的报道窗口
TARGET-CTCA
TARGET-CTCA - Troponin in acute chest pain to guide CTCA
已有发表积累
研究
注册号
NCT03952351
状态
入组完成·随访中
期别/类型
无期别 期 · INTERVENTIONAL
入组
3,170 人(1 国)
启动
2026-01-31
主要研究者
Nicholas Mills · University of Edinburgh - Edinburgh, United Kingdom of Great Britain & Northern Ireland
主要终点
心肌梗死或心脏死亡复合终点
文章
Trials · 2023 · PMID 37312104
The majority of patients with suspected acute coronary syndrome presenting to the emergency department will be discharged once myocardial infarction has been ruled out, although a proportion will have unrecognised coronary artery disease. In this setting, high-sensitivity cardiac troponin identifies those at increased …
TAVI PCI
TAVI PCI: Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention
已有发表积累
研究
注册号
NCT04310046
状态
入组完成·随访中
期别/类型
无期别 期 · INTERVENTIONAL
入组
986 人(6 国)
启动
2020-09-30
主要研究者
Barbara Elisabeth Stahli · University Hospital Zurich - Zurich, Switzerland
主要终点
主要结果指标为经历主要结果指标的参与者数
文章
The Canadian journal of cardiology · 2026 · PMID 42385979
Pre-TAVI PCI yielded no hard clinical benefits and likely increased major bleeding risk. Although it reduced subsequent revascularizations, a soft, clinician-driven endpoint, this did not improve hospital-free survival. These findings strongly support a selective, lesion-guided approach over routine intervention.
TRIC-I-HF
TRIC-I-HF: Tricuspid Intervention in Heart Failure
全球首发信号
研究
注册号
NCT05784883
状态
入组完成·随访中
期别/类型
— · OBSERVATIONAL
入组
700 人(1 国)
启动
2022-08-01
主要研究者
Joerg Hausleiter · Ludwig Maximilians University - Munich, Germany
主要终点
老年三尖瓣反流患病率 ① 全因死亡率 ① 心血管死亡率
首发
会前无公开结果文献 —— ESC 2026 现场即全球首发的报道窗口
Time-dependent effects of physiology-guided staged complete revascularisation in ST-segment elevation myocardial infarction with MVD disease
Time-dependent effects of physiology-guided staged complete revascularisation in ST-segment elevation myocardial infarction with MVD disease: a multicentre, open -labelled, randomised STAGED trial
资料待补
数据缺口与信号
  • CT.gov 无注册记录匹配(观察性研究/本地注册试验可能未入 CT.gov)
  • 会前无同研究公开文献 → 结果全球首发,既往只有设计/方案文献或全无
Vericiguat in Vasospastic Angina (ViVA)
The Vericiguat in Vasospastic Angina (ViVA) trial: a double-blind placebo-controlled randomized cross-over study
已有发表积累
研究
注册号
NCT06917287
状态
入组完成·随访中
期别/类型
无期别 期 · INTERVENTIONAL
入组
114 人(1 国)
启动
2025-04-20
主要研究者
Hanae Namba · Amsterdam University Medical Centre (AUMC) - Amsterdam, Netherlands (The)
主要终点
评估Native CT-II对膝关节健康的影响,以改良WOMAC总分较基线变化衡量
文章
American heart journal · 2026 · PMID 42034271
Coronary vasospasm is highly prevalent in patients with angina and no obstructive coronary arteries (ANOCA). In the pathophysiology of coronary vasospasm, endothelial dysfunction and vascular smooth muscle cell hyperreactivity may cause an imbalance between vasodilation and vasoconstriction. Within this pathophysiology…